Brief: Zhaoke Ophthalmology Says FY Loss RMB1.76 Bln Vs Loss Of RMB670 Mln
March 23 (Reuters) - Zhaoke Ophthalmology Ltd 6622.HK :
* FY LOSS RMB1.76 BILLION VERSUS LOSS OF RMB670 MILLION
* NON-HKFRS ADJUSTED LOSS FOR YEAR RMB228.3 MILLION VERSUS
RMB95.7
MILLION
* SEES COMMERCIALIZING OF GENERIC DRUGS, INCLUDING
BIMATOPROST
TIMOLOL FROM 2022, LEADING TO NEAR-TERM REVENUE
Source text for Eikon: ID:nHKS948Px3
Further company coverage: 6622.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zhaoke Ophthalmology
See all newsBrief: Zhaoke Ophthalmology Says Its Facility In Guangzhou Obtains GMP Certification From Australia's TGA
China's Zhaoke Ophthalmology H1 revenue rises
Brief: Zhaoke Ophthalmology Says Yuvezzitm Approved By Macau Pharmaceutical Administration Bureau
Brief: Zhaoke Ophthalmology Enters Into Definitive Agreement For Acquisition Of Global Rights To NVK002
Brief: Zhaoke Ophthalmology Says Yuvezzitm Approved For Use At Boao Super Hospital